Key Points
-
The myelin sheath is one of the best studied mammalian membranes, not least because of its vital function, and also owing to its abundance and the ease of isolation of enriched myelin fractions. This review highlights four crucial stages of myelination, namely, the selection of axons and initiation of cell–cell interaction between these and glial cells, the establishment of stable intercellular contact and assembly of the nodes of Ranvier, regulation of myelin thickness and, finally, longitudinal extension of myelin segments in response to the lengthening of axons during postnatal growth.
-
The reasons why some axons are myelinated and others are not is still baffling. In general, a minimum calibre is required (∼1 μm) before an axon can be myelinated. It has recently been shown that nerve growth factor (NGF) might also have a role in regulating myelination. NGF stimulates myelination by Schwann cells but inhibits oligodendrocyte-mediated myelination, and these effects seem to be indirect — that is, the signals that affect myelination arise from axons in response to the binding of NGF to axonal tyrosine kinase TrkA receptors.
-
Myelin basic protein is synthesized in the growing myelin process from mRNA that is transported there in a microtubule-dependent fashion. The microfilament system also has a role through the small GTPase Rho, and intact microfilaments are essential for process extension and the expression of myelin-related genes.
-
Ensheathment by myelin-forming glia and the formation of nodes of Ranvier are almost certainly inextricably linked. Nevertheless, formation of the major adhesive junction between axons and glia, the paranodal axo–glial junction, is not essential for nodal formation, although it probably has a role in helping to maintain the tight clustering of nodal components in the mature nerve. It is still not certain that the mechanisms for the assembly of the axon initial segments are identical to those that operate at the node, despite their similar protein compositions.
-
The ratio of myelin thickness to axonal diameter is remarkably constant and axonally-derived neuregulin (NrgI type III) seems to have an important role, as myelin sheaths are thicker when it is over expressed. Brain-derived neurotrophic factor and the neurotrophin receptor p75 have also been implicated in regulating later stages of myelination, including myelin thickness. By contrast, the length of internodes, at least in the PNS, is regulated by Cajal bands in a Schwann cell autonomous fashion.
Abstract
The evolution of complex nervous systems in vertebrates has been accompanied by, and probably dependent on, the acquisition of the myelin sheath. Although there has been substantial progress in our understanding of the factors that determine glial cell fate, much less is known about the cellular mechanisms that determine how the myelin sheath is extended and stabilized around axons. This review highlights four crucial stages of myelination, namely, the selection of axons and initiation of cell–cell interactions between them and glial cells, the establishment of stable intercellular contact and assembly of the nodes of Ranvier, regulation of myelin thickness and, finally, longitudinal extension of myelin segments in response to the lengthening of axons during postnatal growth.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lazzarini, R. A. (ed.) Myelin Biology and Disorders (Elsevier, San Diego, USA, 2004).
Jessen, K. R. & Mirsky, R. The origin and development of glial cells in peripheral nerves. Nature Rev. Neurosci. 6, 671–682 (2005).
Colognato, H. & ffrench-Constant, C. Mechanisms of glial development. Curr. Opin. Neurobiol. 14, 37–44 (2004).
Bjartmar, C., Wujek, J. R. & Trapp, B. D. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 206, 165–171 (2003). This review discusses the evidence showing that in multiple sclerosis axonal loss begins at disease onset and correlates with the degree of inflammation in demyelinated lesions.
Charles, P. et al. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 125, 1972–1979 (2002).
Haney, C. A. et al. Heterophilic binding of L1 on unmyelinated sensory axons mediates Schwann cell adhesion and is required for axonal survival. J. Cell Biol. 146, 1173–1184 (1999).
Cohen, N. R. et al. Errors in corticospinal axon guidance in mice lacking the neural cell adhesion molecule L1. Curr. Biol. 8, 26–33 (1998).
Baron, W., Colognato, H. & ffrench-Constant, C. Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 49, 467–479 (2005).
Colognato, H. & ffrench-Constant, C. Mechanisms of glial development. Curr. Opin. Neurobiol. 14, 37–44 (2004).
Feltri, M. L. et al. Conditional disruption of β 1 integrin in Schwann cells impedes interactions with axons. J. Cell Biol. 156, 199–209 (2002).
Yang, D. et al. Coordinate control of axon defasciculation and myelination by laminin-2 and -8. J. Cell Biol. 168, 655–666 (2005).
Saito, F. et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38, 747–758 (2003).
Cohen, S. & Levi-Montalcini, R. Purification and properties of a nerve growth-promoting factor isolated from mouse sarcoma 180. Cancer Res. 17, 15–20 (1957).
Levi-Montalcini, R. & Cohen, S. Effects of the extract of the mouse submaxillary salivary glands on the sympathetic system of mammals. Ann. NY Acad. Sci. 85, 324–341 (1960).
Chan, J. R. et al. NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43, 183–191 (2004). Shows that neurotrophins can modulate the receptiveness of axons to myelin ensheathment.
Stevens, B., Porta, S., Haak, L. L., Gallo, V. & Fields, R. D. Adenosine: a neuron–glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 36, 855–868 (2002).
Munro, S. Lipid rafts: elusive or illusive? Cell 115, 377–388 (2003).
Saher, G. et al. High cholesterol level is essential for myelin membrane growth. Nature Neurosci. 8, 468–475 (2005).
Bosio, A., Bussow, H., Adam, J. & Stoffel, W. Galactosphingolipids and axono–glial interaction in myelin of the central nervous system. Cell Tissue Res. 292, 199–210 (1998).
Coetzee, T. et al. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86, 209–219 (1996).
Dupree, J. L., Coetzee, T., Blight, A., Suzuki, K. & Popko, B. Myelin galactolipids are essential for proper node of Ranvier formation in the CNS. J. Neurosci. 18, 1642–1649 (1998).
Hirahara, Y., Bansal, R., Honke, K., Ikenaka, K. & Wada, Y. Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice. Glia 45, 269–277 (2004).
Ishibashi, T. et al. A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J. Neurosci. 22, 6507–6514 (2002).
Brophy, P. J., Horvath, L. I. & Marsh, D. Stoichiometry and specificity of lipid–protein interaction with myelin proteolipid protein studied by spin-label electron spin resonance. Biochemistry 23, 860–865 (1984).
Colman, D. R., Kreibich, G., Frey, A. B. & Sabatini, D. D. Synthesis and incorporation of myelin polypeptides into CNS myelin. J. Cell Biol. 95, 598–608 (1982). One of the first demonstrations of local mRNA translation in a eukaryotic cell.
Court, F. A. et al. Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431, 191–195 (2004). Describes how Cajal bands are formed in myelinating Schwann cells and proposes a function for them in Schwann cell growth.
Griffiths, I. R. et al. Expression of myelin protein genes in Schwann cells. J. Neurocytol. 18, 345–352 (1989).
Gould, R. M., Freund, C. M., Palmer, F. & Feinstein, D. L. Messenger RNAs located in myelin sheath assembly sites. J. Neurochem. 75, 1834–1844 (2000).
Brumwell, C., Antolik, C., Carson, J. H. & Barbarese, E. Intracellular trafficking of hnRNP A2 in oligodendrocytes. Exp. Cell Res. 279, 310–320 (2002).
Kosturko, L. D., Maggipinto, M. J., D'Sa, C., Carson, J. H. & Barbarese, E. The microtubule-associated protein, TOG, binds to the RNA trafficking protein, hnRNP A2. Mol. Biol. Cell 16, 1938–1947 (2005). Provides a molecular mechanism for transporting RNA granules in oligodendrocytes.
Kim, J. et al. Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc. Natl Acad. Sci. USA 101, 360–365 (2004).
Krichevsky, A. M. & Kosik, K. S. Neuronal RNA granules: a link between RNA localization and stimulation-dependent translation. Neuron 32, 683–696 (2001).
Melendez-Vasquez, C. V., Einheber, S. & Salzer, J. L. Rho kinase regulates Schwann cell myelination and formation of associated axonal domains. J. Neurosci. 24, 3953–3963 (2004). Identifies a signalling pathway in Schwann cells that involves the actin cytoskeleton and that permits the Schwann cell to respond to axonal contact, which, in turn, leads to domain segregation in the axon.
Jaillard, C. et al. Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J. Neurosci. 25, 1459–1469 (2005).
Wilkins, A., Majed, H., Layfield, R., Compston, A. & Chandran, S. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J. Neurosci. 23, 4967–4974 (2003).
Liang, X., Draghi, N. A. & Resh, M. D. Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J. Neurosci. 24, 7140–7149 (2004).
Fernandez-Valle, C., Gorman, D., Gomez, A. M. & Bunge, M. B. Actin plays a role in both changes in cell shape and gene-expression associated with Schwann cell myelination. J. Neurosci. 17, 241–250 (1997).
Bunge, R. P., Bunge, M. B. & Bates, M. Movements of the Schwann cell nucleus implicate progression of the inner (axon-related) Schwann cell process during myelination. J. Cell Biol. 109, 273–284 (1989).
Poliak, S. & Peles, E. The local differentiation of myelinated axons at nodes of Ranvier. Nature Rev. Neurosci. 4, 968–980 (2003).
Salzer, J. L. Polarized domains of myelinated axons. Neuron 40, 297–318 (2003).
Einheber, S. et al. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J. Cell Biol. 139, 1495–1506 (1997).
Menegoz, M. et al. Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 19, 319–331 (1997).
Rios, J. C. et al. Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination. J. Neurosci. 20, 8354–8364 (2000).
Tait, S. et al. An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J. Cell Biol. 150, 657–666 (2000).
Arroyo, E. J. et al. Genetic dysmyelination alters the molecular architecture of the nodal region. J. Neurosci. 22, 1726–1737 (2002).
Bhat, M. A. et al. Axon–glia interactions and the domain organization of myelinated axons requires Caspr/Paranodin. Neuron 30, 369–383 (2001).
Boyle, M. E. T. et al. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 30, 385–397 (2001).
Kaplan, M. R. et al. Induction of sodium channel clustering by oligodendrocytes. Nature 386, 724–728 (1997). Physical contact between oligodendrocytes and the neurites of retinal ganglion cells is not necessary for the induction of sodium channel clustering.
Lustig, M. et al. Nr-CAM and neurofascin interactions regulate ankyrin G and sodium channel clustering at the node of Ranvier. Curr. Biol. 11, 1864–1869 (2001).
Sakurai, T. et al. Overlapping functions of the cell adhesion molecules Nr-CAM and L1 in cerebellar granule cell development. J. Cell Biol. 154, 1259–1273 (2001).
Ango, F. et al. Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at purkinje axon initial segment. Cell 119, 257–272 (2004).
Komada, M. & Soriano, P. βIV-spectrin regulates sodium channel clustering through ankyrin-G at axon initial segments and nodes of Ranvier. J. Cell Biol. 156, 337–348 (2002).
Garrido, J. J. et al. A targeting motif involved in sodium channel clustering at the axonal initial segment. Science 300, 2091–2094 (2003).
Riethmacher, D. et al. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 389, 725–730 (1997).
Garratt, A. N., Voiculescu, O., Topilko, P., Charnay, P. & Birchmeier, C. A dual role of erbB2 in myelination and in expansion of the Schwann cell precursor pool. J. Cell Biol. 148, 1035–1046 (2000).
Michailov, G. V. et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700–703 (2004). Transgenic overexpression of the NRG1 type III protein in neurons regulates myelin thickness.
Tolwani, R. J. et al. BDNF overexpression produces a long-term increase in myelin formation in the peripheral nervous system. J. Neurosci. Res. 77, 662–669 (2004).
Brill, M. H., Waxman, S. G., Moore, J. W. & Joyner, R. W. Conduction velocity and spike configuration in myelinated fibres: computed dependence on internode distance. J. Neurol. Neurosurg. Psychiatry 40, 769–774 (1977).
Hursh, J. B. Conduction velocity and diameter of nerve fibers. Am. J. Physiol. 127, 131–139 (1939).
Jacobs, J. M. On internodal length. J. Anat. 157, 153–162 (1988).
Gillespie, C. S. et al. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 26, 523–531 (2000).
Sherman, D. L., Fabrizi, C., Gillespie, C. S. & Brophy, P. J. Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 30, 677–687 (2001).
Ramón y Cajal, S. Histology (Bailliere, Tindall & Cox, London, 1933).
McIntyre, C. C., Richardson, A. G. & Grill, W. M. Modeling the excitability of mammalian nerve fibers: influence of afterpotentials on the recovery cycle. J. Neurophysiol. 87, 995–1006 (2002).
Suter, U. & Scherer, S. S. Disease mechanisms in inherited neuropathies. Nature Rev. Neurosci. 4, 714–726 (2003).
Lappe-Siefke, C. et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nature Genet. 33, 366–374 (2003). Axonal degeneration occurs in mice that lack a functional Cnp1 gene in their oligodendrocytes, even though myelin deposition seems quite normal. This indicates that other factors in the oligodendrocytes, apart from myelin, are important for the trophic function of myelin-forming glia.
de Waegh, S. M., Lee, V. M. & Brady, S. T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68, 451–463 (1992). Showed that signalling by myelin-forming glia to axons influences the extent of neurofilament phosphorylation, and therefore the calibre, of axons.
Edgar, J. M. et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J. Cell Biol. 166, 121–131 (2004).
LaMonte, B. H. et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34, 715–727 (2002).
Reid, E. et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am. J. Hum. Genet. 71, 1189–1194 (2002).
Xia, C. H. et al. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J. Cell Biol. 161, 55–66 (2003).
Zhao, C. et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ. Cell 105, 587–597 (2001).
Morfini, G. et al. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 23, 2235–2245 (2004).
Boiko, T. et al. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 30, 91–104 (2001).
Kaplan, M. R. et al. Differential control of clustering of the sodium channels Nav1. 2 and Nav1. 6 at developing CNS nodes of Ranvier. Neuron 30, 105–119 (2001).
Acknowledgements
Work in the authors' laboratory is supported by the Medical Research Council, the Wellcome Trust and the Multiple Sclerosis Society.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Glossary
- MULTIPLE SCLEROSIS
-
A disease of the CNS that is characterized by focal areas in which myelin is lost from axons, leading to axon degeneration.
- NEUREGULINS
-
A family of receptor tyrosine kinases related to epidermal growth factor (EGF). The receptors for neuregulins are the ErbB family of tyrosine kinase transmembrane receptors.
- LIPID RAFTS
-
Domains within plasma membranes believed to be enriched in cholesterol and glycolipids that are proposed to aid the delivery of subsets of membrane proteins to the plasma membrane and serve as sites for concentrating signalling molecules.
- PARANODAL AXO–GLIAL JUNCTIONS
-
Major sites of physical interaction between myelin-forming glial cells and the axon that lie on either side of the nodes of Ranvier and are characterized by septate-like junctions.
- Rho, Cdc42 AND Rac
-
Rho GTPases are small (20–30 kDa) GTP-binding proteins of the Ras superfamily and are divided into three main subgroups, Rho, Cdc42 and Rac, which have distinct effects on microfilament dynamics.
- PERIAXIN
-
A protein of myelinating Schwann cells that is concentrated at zones of adhesion between the abaxonal (outermost) myelin lamella and the Schwann cell plasma membrane in a complex with DRP2 and dystroglycan.
- CAJAL BANDS
-
Cytoplasmic channels that lie beneath the surface of the Schwann cell plasma membrane and that are separated from each other by the appositions formed by the periaxin–DRP2–dystroglycan complexes.
- CHARCOT-MARIE-TOOTH DISEASE
-
An inherited degenerative neuropathy of the PNS that is caused by more than 30 different mutations. Although most forms are primarily demyelinating, loss of proper glial contact generally results in axonal degeneration.
Rights and permissions
About this article
Cite this article
Sherman, D., Brophy, P. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 6, 683–690 (2005). https://doi.org/10.1038/nrn1743
Issue Date:
DOI: https://doi.org/10.1038/nrn1743